Tag Archives: research

July, 2018

20 July
Amgen and Cedars-Sinai Collaborate on Research, Health Service Redesign and Outcomes-Based Care

THOUSAND OAKS, Calif. and LOS ANGELES, July 19, 2018 /PRNewswire/ — Amgen (NASDAQ:AMGN) and Cedars-Sinai Medical Center today announced a partnership to help support the improvement of healthcare quality in the treatment of multiple therapeutic areas that could include oncology, cardiovascular disease, osteoporosis and migraine. The organizations intend to jointly undertake research projects in one or more of …
Share

3 May
Bristol-Myers Squibb and Flatiron Health Expand Collaboration to Accelerate Cancer Research and Development Efforts

NEW YORK–(BUSINESS WIRE)–Bristol-Myers Squibb (NYSE:BMY) and Flatiron Health, a market leader in oncology-specific electronic health record software and the curation of regulatory-grade real-world data for cancer research and real-world evidence (RWE) generation, expanded their relationship today by announcing a three-year collaboration agreement. Bristol-Myers Squibb will use Flatiron’s real-world data to …
Share

26 May
President’s Budget Threatens to Stall Nation’s Progress Against Cancer

ASCO strongly opposes the Administration’s proposed cuts to federal agencies that support biomedical research and Medicaid for Fiscal Year 2018, including a 21 percent proposed funding cut for the National Institutes of Health (NIH), a 20 percent proposed funding cut for the National Cancer Institute (NCI), and reducing Medicaid funding …
Share

3 March
Boehringer Ingelheim Expands Collaboration with Vanderbilt University for Difficult-to-Treat Cancers

INGELHEIM, Germany–(BUSINESS WIRE)–Boehringer Ingelheim announced today a new collaboration with Vanderbilt University, Nashville, Tennessee. The multi-year program complements an already existing collaboration by focusing on the research and development of small molecule compounds targeting the protein SOS (Son Of Sevenless). This molecule activates KRAS, a molecular switch that plays a …
Share

15 June
New Genetic Research Can Significantly Improve Drug Development

With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars? According to a new study published in the International Journal of Epidemiology this week, genetic research …
Share

18 November
IMS Report Forecasts Global Drug Spend to Rise to $1.4 Trillion in 2020

DANBURY, CT, November 18, 2015 – More than half of the world’s population will live in countries where medicine use will exceed one dose per person per day by 2020, up from 31 percent in 2005, as the “medicine use gap” between developed and pharmerging markets narrows. According to new …
Share

6 May
23andMe and Pfizer Launch Study to Better Understand the Genetics of Lupus

During Lupus Awareness Month, drug giant Pfizer Inc. is teaming up with leading personal genetics company 23andMe to launch the Lupus Research Study. The companies announced that they will collaborate to launch the study, which aims to enroll 5,000 patients with systemic lupus erythematosus to help better understand the genetics …
Share